Skip to main content

All Miami Cancer Institute

Submissions from 2018 2018

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02, Minesh Mehta

Pre-Hospital FAST-ED Initiatives Improve t-PA and Endovascular Treatment Times, Amy Starosciak, Maygret Ramirez, Ivis Gonzalez, Virginia Ramos, Jayme Strauss, and Felipe De Los Rios La Rosa

Submissions from 2017 2017

Symptom Screening Improves Accuracy of the FAST-ED Scale, Amy Starosciak, Maygret Ramirez, Jayme Strauss, Virginia Ramos, Ivis Gonzalez, and Felipe De Los Rios La Rosa

The Road to Target: Stroke Honor Roll Elite Plus, Jayme Strauss, Andrew Waisbrot, Daniel Hartnett, and Amy Starosciak

Thrombolysis of a stroke patient with history of rtPA-associated angioedema, Felipe De Los Rios La Rosa, Amy Starosciak, and Brian Wolf

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA), Minesh Mehta

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee, Michael Chuong

MBA degree is needed for leadership roles in Medical Physics profession, Alonso Gutierrez

Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets, Murugesan Manoharan

Comparison of initial patient setup accuracy between surface imaging and three point localization: A retrospective analysis, Alonso Gutierrez

Changing Dogma and Decreased Collateral Damage in Breast Cancer Care, Jane Mendez

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions, Jane Mendez

Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema, Recommendations from an Expert Panel: Part 2: Preventive and Therapeutic Options, Jane Mendez

Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation, Minesh Mehta

State of the art: the evolving role of RT in combined modality therapy for GBM, Minesh Mehta

The role of radiation in treating glioblastoma: here to stay, Minesh Mehta

The three paradigm shifts of the 1980s and the AAS, Michael Zinner

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper, John Paul Diaz and Jeffrey Boyd

The Changing Role of Whole-Brain Radiotherapy: Demise or Time for Selective Usage?, Minesh Mehta

The Next Journey: Moving Forward After Cancer Diagnosis and Treatment, Jane Arboleda

The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases, Minesh Mehta

A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients, Michael Chuong and Minesh Mehta

A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas, Minesh Mehta

Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options, Yazmin Odia

Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation, Minesh Mehta